Table of Content

Open Access iconOpen Access

ARTICLE

Pulmonary hypertension: Barrier or just a bump in the road in transplanting adults with congenital heart disease

Jonathan N. Menachem1, Edo Y. Birati2, Payman Zamani2, Anjali T. Owens2, Pavan Atluri3, Christian A. Bermudez3, David Drajpuch2, Stephanie Fuller4, Yuli Y. Kim2, Christopher E. Mascio4, Vikram Palanivel2, J. Eduardo Rame2, Joyce Wald2, Michael A. Acker3, Jeremy A. Mazurek2

1 Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA
2 Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
3 Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
4 Division of Cardiothoracic Surgery, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

* Corresponding Author: Jonathan Menachem, MD, Vanderbilt University Medical Center, Medical Center East, 1215 21st Avenue South, Nashville, TN 37232. Email: jonathan.n.menachem@vanderbilt. edu

Congenital Heart Disease 2018, 13(4), 492-498. https://doi.org/10.1111/chd.12606

Abstract

Background: Heart failure (HF) is the leading cause of death in adults with congenital heart disease (ACHD). Identification of disease progression and timing of referral for advanced therapies is often delayed. However, increased awareness and understanding of ACHD and improvements in the approach to treatment have led to improved outcomes. Pulmonary hypertension (PH) is a common barrier to HT. In ACHD, the approach to PH and HT is quite complicated, given the anatomic heterogeneity and lower prevalence and experience. However, in some cases, PH is a result of elevated systemic filling pressures and low output.
Methods: We describe the approach used to successfully transplant an ACHD patient with severe pre-HT PH performing HT alone. We review the literature and describe the one patient’s journey from primarily palliative, to a combined heart-lung transplant candidate, to successful HT patient.
Results: We discuss the methodology used to successfully transplant a patient, with significantly elevated pulmonary pressures and an initial pulmonary vascular resistance (PVR)> 13 Wood units.
Conclusions: There are a number of complexities associated with the ACHD population and it is of utmost importance to carefully identify the underlying hemodynamic milieu and inform the appropriate treatment course in order to have successful transplant outcomes.

Keywords


Cite This Article

APA Style
Menachem, J.N., Birati, E.Y., Zamani, P., Owens, A.T., Atluri, P. et al. (2018). Pulmonary hypertension: barrier or just a bump in the road in transplanting adults with congenital heart disease. Congenital Heart Disease, 13(4), 492-498. https://doi.org/10.1111/chd.12606
Vancouver Style
Menachem JN, Birati EY, Zamani P, Owens AT, Atluri P, Bermudez CA, et al. Pulmonary hypertension: barrier or just a bump in the road in transplanting adults with congenital heart disease. Congeni Heart Dis. 2018;13(4):492-498 https://doi.org/10.1111/chd.12606
IEEE Style
J.N. Menachem et al., “Pulmonary hypertension: Barrier or just a bump in the road in transplanting adults with congenital heart disease,” Congeni. Heart Dis., vol. 13, no. 4, pp. 492-498, 2018. https://doi.org/10.1111/chd.12606



cc Copyright © 2018 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1278

    View

  • 1000

    Download

  • 0

    Like

Share Link